Cipla

Cipla promoters sell shares worth over Rs 1,835 crore

5 Indian pharma companies would jointly conduct a clinical trial of COVID drug

Vaccine no. 4 is almost here, Cipla gets nod to import Moderna jab

Scrutinise roles of MLA Zeeshan, Sonu Sood in getting anti-COVID drugs: HC

What is an antibody cocktail, is it effective against COVID-19, Zee explains

Moderna to launch single-dose COVID-19 vaccine in India likely next year

Roche, Cipla launch Antibody Cocktail for treatment of mild to moderate COVID

Cipla witnesses 3 senior-level exits including India biz CEO

Glenmark, Cipla stocks surge after nod to launch drugs for COVID-19

IndusInd Bank, Yes Bank to join BSE Sensex; Cipla, Lupin exit

Indian equities trade flat with marginal losses, healthcare stocks slip

Cancer drug: SC allows Cipla to withdraw appeal against Roche

Investor wealth surges over Rs 50 lakh crore in 3 years

Cipla shares down 3%; mcap dips Rs 1,003 crore post Q4 results

Cipla gets USFDA nod for generic HIV drug

634 drugs on NPPA's price ceiling non-compliant list

Cipla initiates campaign for a pollution free Delhi; starts #saveyourlungsdilli

Cipla appoints Ireena Vittal as independent director

Cipla gets four USFDA observations for three Goa facilities; stocks fall over 3%